As shown in Fig. 6, 1,5-AG (0.2–0.8 mM) markedly increased phosphorylation of ERK1/2 and improved the activity of MAPK/ERK signaling in pre-B ALL cells (Fig. 6A, B). This evidence concerns the gene MAPK3 and acute lymphoblastic leukemia.